Brought to you by:
Philips expands commercial availability of LumiGuide imaging system
Philips has announced the expanded commercial availability of LumiGuide 3D device guidance—the much-heralded first real-time artificial intelligence (AI)-enabled light-based navigation solution for image-guided therapy—across Europe and the U.S. LumiGuide integrates with Philips’ Azurion platform, which is designed to drive procedural…
Philips issues Class I recall for Tack endovascular system
Philips has recently announced that it will no longer sell its Tack endovascular system in the U.S. following a Class I recall issued by the Food and Drug Administration (FDA). A Class I recall is the FDA’s most serious classification,…
First patient enrolled in study of integrated laser atherectomy and IVL catheter
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy (IVL) catheter. Procedures that previously required the use of two different devices can…
Philips announces FDA approval for enhanced LumiGuide guidewire, marks 1000th patient treated with 3D guidance technology
Royal Philips today announced the introduction of the 160cm Food and Drug Administration (FDA)-approved version of its LumiGuide endovascular navigation wire. This enhanced LumiGuide guidewire, which utilises the company’s Fiber Optic RealShape (FORS) technology, was used for the first time…
First post-FDA approval implant of Duo venous stent system announced
Royal Philips today announced the first implant of the Duo venous stent system, indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the Food and Drug Association (FDA). On June…
FORS-powered LumiGuide 3D imaging technology is rolled out at specialized centers in U.S. and Europe
Andres Schanzer, MD, has hailed it “one of the most exciting changes” seen in imaging during the course of his career. Philips’ LumiGuide “human GPS” technology—which uses light reflected along an optical fiber inside a guidewire to generate three-dimensional (3D),…
Use of IVUS reduces patient risk of MALE or death by up to 28%: Data support consensus views on importance of advanced visualization for peripheral vascular disease interventions
This advertorial is sponsored by Philips. The benefits of utilizing intravascular ultrasound (IVUS) in peripheral vascular interventions has been widely demonstrated in the literature. In nearly every vascular bed studied, we have seen an improvement in overall outcomes. Over the…
Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower-extremity arterial and venous interventions. Published…
Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series
Royal Philips has announced physicians will now have access to advanced new 3D image guidance capabilities through its image-guided therapy mobile C-arm system—Zenition. The system will deliver enhanced clinical accuracy and efficiency, according to Philips, and aims to improve outcomes…
ISET 2022 audience hears latest data on endovascular therapies
At this year’s International Symposium on Endovascular Therapy (ISET), being held Jan. 16–19 in Hollywood, Florida, experts presented an array of late-breaking trial results on topics ranging from venous stenting to abdominal aortic aneurysm (AAA) sac sealing. Waseem Wahood, MS, a…